<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00565682</url>
  </required_header>
  <id_info>
    <org_study_id>DOLAAR</org_study_id>
    <nct_id>NCT00565682</nct_id>
  </id_info>
  <brief_title>Pain Post Abdominal Laparoscopy Prevention With Arcoxia</brief_title>
  <official_title>Pain Post Abdominal Laparoscopy Prevention With Arcoxia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Vozandez</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Merck Sharp &amp; Dohme Corp.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital Vozandez</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To test the analgesic efficacy of etoricoxib used before a surgical procedure compared to the
      already known effect when administered after such a procedure. Patient will be receiving
      either etoricoxib or the respective placebo one hour before surgery, then two hours after
      those receiving the active will receive placebo and those that received placebo will be given
      etoricoxib. Pain score measurements will be performed sequentially. Rescue medication will be
      available all the time.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2006</start_date>
  <completion_date type="Actual">December 2006</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To measure the amount of rescue medication (opioid) needed to relief</measure>
    <time_frame>Every hour after surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>To determine the overall analgesic effect using the visual analog scale (VAS)</measure>
    <time_frame>Every hour after surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Laparoscopic Surgery for Appendicitis</condition>
  <condition>Laparoscopic Surgery for Cholecystitis</condition>
  <condition>Laparoscopic Surgery for Ovarian Cysts</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Etoricoxib 120 mg</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>etoricoxib 120 mg</intervention_name>
    <description>etoricoxib 120 mg, tablet, orally, OD</description>
    <arm_group_label>A</arm_group_label>
    <other_name>Arcoxia</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Voluntary acceptance to participate in the study and signed the informed consent form

          -  Age older than 18 years old and younger than 70 years

          -  Diagnosis of appendicitis, cholecystitis or ovarian cysts suitable of laparoscopic
             surgery

        Exclusion Criteria:

          -  Age less than 18 years or older than 70 years.

          -  Laparoscopic procedures for diagnostic purposes.

          -  Current use of anticoagulants.

          -  Known hypersensitivity to etoricoxib or its components.

          -  History of a CABG or MI (less than 1 year)

          -  History of unstable angina (over the past six months).

          -  Current inflammatory bowel disease.

          -  Uncontrolled hypertension or heart failure

          -  Renal dysfunction/impairment (creatinine clearance &lt; 30ml/min)

          -  Cirrhosis or severe hepatic dysfunction

          -  Any degree of dehydration (mild to severe)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eduardo Noboa, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Vozandez</affiliation>
  </overall_official>
  <verification_date>November 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 29, 2007</study_first_submitted>
  <study_first_submitted_qc>November 29, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 30, 2007</study_first_posted>
  <last_update_submitted>November 29, 2007</last_update_submitted>
  <last_update_submitted_qc>November 29, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 30, 2007</last_update_posted>
  <responsible_party>
    <name_title>Eduardo Noboa</name_title>
    <organization>Hospital Vozandez</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Appendicitis</mesh_term>
    <mesh_term>Cholecystitis</mesh_term>
    <mesh_term>Acalculous Cholecystitis</mesh_term>
    <mesh_term>Ovarian Cysts</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Etoricoxib</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

